Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers

Clinical Therapeutics- United States

doi 10.1016/j.clinthera.2018.09.006

Full Text

Abstract

Available in

Date

November 1, 2018

Authors

Publisher

Elsevier BV

Related search

ME-401, a NOVEL, ORAL, POTENT AND SELECTIVE INHIBITOR OF PHOSPHATIDYLINOSITOL 3-Kinase P110δ (PI3Kδ) IN EARLY CLINICAL DEVELOPMENT FOR B-Cell LYMPHOID MALIGNANCIES

Hematological Oncology

English

Pharmacokinetics and Pharmacodynamics of Verapamil Following Sublingual and Oral Administration to Healthy Volunteers.

British Journal of Clinical Pharmacology

Pharmacology

1992

English

The Pharmacokinetics and Bioavailability of Rabeprazole Following Single Intravenous Infusion and Oral Administration in Healthy Chinese Volunteers

Drugs and Therapy Studies

2011

English

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers

Psychopharmacology

Pharmacology

2019

English

Pharmacokinetics and Pharmacodynamics of Multiple-Dose Intravenous Nemonoxacin in Healthy Chinese Volunteers

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2014

English

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker

Clinical Cancer Research

Cancer Research

Oncology

2009

English

Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

Frontiers in Pharmacology

Pharmacology

2015

English

Pharmacokinetics of Ofloxacin in Male Volunteers Following Oral Administration

Pakistan Journal of Biological Sciences

Agronomy

Crop Science

2002

English

Erratum to : Pharmacokinetics, Pharmacodynamics, and Safety of Bevantolol, a New Β1-Selective Β-Adrenoceptor Antagonist, in Japanese Healthy Volunteers

Japanese Journal of Clinical Pharmacology and Therapeutics

Pharmacology

1992

English

Amanote Research

Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers

Clinical Therapeutics- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

ME-401, a NOVEL, ORAL, POTENT AND SELECTIVE INHIBITOR OF PHOSPHATIDYLINOSITOL 3-Kinase P110δ (PI3Kδ) IN EARLY CLINICAL DEVELOPMENT FOR B-Cell LYMPHOID MALIGNANCIES

Pharmacokinetics and Pharmacodynamics of Verapamil Following Sublingual and Oral Administration to Healthy Volunteers.

The Pharmacokinetics and Bioavailability of Rabeprazole Following Single Intravenous Infusion and Oral Administration in Healthy Chinese Volunteers

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers

Pharmacokinetics and Pharmacodynamics of Multiple-Dose Intravenous Nemonoxacin in Healthy Chinese Volunteers

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker

Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

Pharmacokinetics of Ofloxacin in Male Volunteers Following Oral Administration

Erratum to : Pharmacokinetics, Pharmacodynamics, and Safety of Bevantolol, a New Β1-Selective Β-Adrenoceptor Antagonist, in Japanese Healthy Volunteers

Amanote Research

Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers

Clinical Therapeutics- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

ME-401, a NOVEL, ORAL, POTENT AND SELECTIVE INHIBITOR OF PHOSPHATIDYLINOSITOL 3-Kinase P110δ (PI3Kδ) IN EARLY CLINICAL DEVELOPMENT FOR B-Cell LYMPHOID MALIGNANCIES

Pharmacokinetics and Pharmacodynamics of Verapamil Following Sublingual and Oral Administration to Healthy Volunteers.

The Pharmacokinetics and Bioavailability of Rabeprazole Following Single Intravenous Infusion and Oral Administration in Healthy Chinese Volunteers

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers

Pharmacokinetics and Pharmacodynamics of Multiple-Dose Intravenous Nemonoxacin in Healthy Chinese Volunteers

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker

Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

Pharmacokinetics of Ofloxacin in Male Volunteers Following Oral Administration

Erratum to : Pharmacokinetics, Pharmacodynamics, and Safety of Bevantolol, a New &Beta;1-Selective &Beta;-Adrenoceptor Antagonist, in Japanese Healthy Volunteers

Erratum to : Pharmacokinetics, Pharmacodynamics, and Safety of Bevantolol, a New Β1-Selective Β-Adrenoceptor Antagonist, in Japanese Healthy Volunteers